Important hematological malignancies to consider include myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). MDS and MPN are cancers that impact the volume of certain types of blood cells.
Quest Diagnostics MPN Diagnostic Cascading Reflex looks at genetic mutations to provide physicians a more accurate diagnostic workup for patients suspected of having myeloproliferative neoplasms.
LeukoVantage® is designed to aid in diagnosis, prognosis, and/or treatment strategy for patients with myelodysplastic syndrome using next-generation sequencing (NGS).
Find out what's happening
Quest offers its clients a dedicated oncology customer support line to assist with any test-related questions.
Contact our dedicated customer service team at: 1.833.773.1441
The Quest Hereditary Cancer Screening test portfolio offers you and your patients insights into hereditary risk so you can make more informed decisions together.